In the epidermis of healthy volunteers, LC3 was displayed in all epidermal layers, with the strongest expression in the upper layer, which is consistent with a previous report (25), while this expression was remarkably reduced in the skin lesions of patients with AD (Figure 1A, top panels). Here, MAP1LC3A is linked to Alzheimer disease.